Literature DB >> 15911443

A sensitive adenovirus immunoassay as a model for using nanoparticle label technology in virus diagnostics.

Antti Valanne1, Saila Huopalahti, Tero Soukka, Raija Vainionpää, Timo Lövgren, Harri Härmä.   

Abstract

BACKGROUND: Currently, PCR-based hybridization assays are widely applied in adenovirus diagnostics. However, the technology requires tedious sample preparation, and the amplification phase is susceptible to various contaminants leading to inconvenient and time-consuming assay procedure. Methods relying on viral antigen detection, e.g. immunofluorometric assays (IFMAs) and enzyme immunoassays (EIAs), are less complicated to carry out, but they provide limited sensitivity.
OBJECTIVE: Our aim was to develop a simple and sensitive adenovirus assay based on direct antigen detection via sandwich-forming immunoreaction. The assay employed highly fluorescent europium(III)-chelate-doped nanoparticle labels and selection of high affinity monoclonal antibodies (anti-hexon) coated on label particles and microtitration wells. RESULTS AND
CONCLUSIONS: The extremely high specific activity of the nanoparticle labels enabled the detection limit over 5000 virus particles per millilitre with purified virus particles. The sensitivity was improved by three orders of magnitude (800-fold) compared to concurrent time-resolved IFMA. Furthermore, the nanoparticle assay showed reasonably low coefficients of variation (4.0-20%) and excellent linearity of more than four orders of magnitude (from below 10(5) to 10(9) virus particles per millilitre). Analyzed nasopharyngeal patient specimens revealed a minor disturbance of matrix components, which could be avoided by dilution. The average signal difference between negative and positive samples was nearly four orders of magnitude. The developed assay was sensitive and more convenient approach to adenovirus screening compared to available assays. In addition, the study demonstrates the potential of nanoparticles in sensitive screening of viral analytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15911443     DOI: 10.1016/j.jcv.2004.11.007

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

Review 1.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

2.  Introducing MINA--The Molecularly Imprinted Nanoparticle Assay.

Authors:  Roman V Shutov; Antonio Guerreiro; Ewa Moczko; Isabel Perez de Vargas-Sansalvador; Iva Chianella; Michael J Whitcombe; Sergey A Piletsky
Journal:  Small       Date:  2014-02-06       Impact factor: 13.281

3.  Rapid method for detection of influenza a and B virus antigens by use of a two-photon excitation assay technique and dry-chemistry reagents.

Authors:  Janne O Koskinen; Raija Vainionpää; Niko J Meltola; Jori Soukka; Pekka E Hänninen; Aleksi E Soini
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

Review 4.  Lanthanide-based time-resolved luminescence immunoassays.

Authors:  A K Hagan; T Zuchner
Journal:  Anal Bioanal Chem       Date:  2011-05-11       Impact factor: 4.142

Review 5.  Nanoparticle detection of respiratory infection.

Authors:  Kristin C Halfpenny; David W Wright
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 May-Jun

6.  A novel colorimetric immunoassay utilizing the peroxidase mimicking activity of magnetic nanoparticles.

Authors:  Min-Ah Woo; Moon Il Kim; Jae Hwan Jung; Ki Soo Park; Tae Seok Seo; Hyun Gyu Park
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

Review 7.  Nanobioimaging and sensing of infectious diseases.

Authors:  Padmavathy Tallury; Astha Malhotra; Logan M Byrne; Swadeshmukul Santra
Journal:  Adv Drug Deliv Rev       Date:  2009-11-25       Impact factor: 15.470

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.